Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olga Chernoloz

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Psychiatry Research|April 26, 2025
Calling for PAT clinical trials catering to racially minoritized populations: A letter to the editor regarding Haft et al., (2025)Naomi Faber, Olga Chernoloz
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 21, 2025
Letter to the EditorJeroen Hendriks, Olga Chernoloz
Psychopharmacology|July 31, 2009
Electrophysiological studies in the rat brain on the basis for aripiprazole augmentation of antidepressants in major depressive disorderOlga Chernoloz, Mostafa El Mansari, Pierre Blier
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 1, 2012
Effects of sustained administration of quetiapine alone and in combination with a serotonin reuptake inhibitor on norepinephrine and serotonin transmissionOlga Chernoloz, Mostafa El Mansari, Pierre Blier
Journal of Psychiatry & Neuroscience : JPN|October 26, 2011
Long-term administration of the dopamine D3/2 receptor agonist pramipexole increases dopamine and serotonin neurotransmission in the male rat forebrainOlga Chernoloz, Mostafa El Mansari, Pierre Blier
CNS Neuroscience & Therapeutics|April 22, 2010
Relevance of norepinephrine-dopamine interactions in the treatment of major depressive disorderMostafa El Mansari, Bruno P Guiard, Olga Chernoloz, et al.
BMC Medical Education|October 24, 2024
Expert recommendations for Germany's integration of psychedelic-assisted therapySergio R Perez Rosal, Joseph T La Torre, Susanne Birnkammer, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Psychiatry Research|April 26, 2025
Calling for PAT clinical trials catering to racially minoritized populations: A letter to the editor regarding Haft et al., (2025)Naomi Faber, Olga Chernoloz
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 21, 2025
Letter to the EditorJeroen Hendriks, Olga Chernoloz
Psychopharmacology|July 31, 2009
Electrophysiological studies in the rat brain on the basis for aripiprazole augmentation of antidepressants in major depressive disorderOlga Chernoloz, Mostafa El Mansari, Pierre Blier
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 1, 2012
Effects of sustained administration of quetiapine alone and in combination with a serotonin reuptake inhibitor on norepinephrine and serotonin transmissionOlga Chernoloz, Mostafa El Mansari, Pierre Blier
Journal of Psychiatry & Neuroscience : JPN|October 26, 2011
Long-term administration of the dopamine D3/2 receptor agonist pramipexole increases dopamine and serotonin neurotransmission in the male rat forebrainOlga Chernoloz, Mostafa El Mansari, Pierre Blier
CNS Neuroscience & Therapeutics|April 22, 2010
Relevance of norepinephrine-dopamine interactions in the treatment of major depressive disorderMostafa El Mansari, Bruno P Guiard, Olga Chernoloz, et al.
BMC Medical Education|October 24, 2024
Expert recommendations for Germany's integration of psychedelic-assisted therapySergio R Perez Rosal, Joseph T La Torre, Susanne Birnkammer, et al.
Pageof 1